725 related articles for article (PubMed ID: 34083781)
1. Interleukins in cancer: from biology to therapy.
Briukhovetska D; Dörr J; Endres S; Libby P; Dinarello CA; Kobold S
Nat Rev Cancer; 2021 Aug; 21(8):481-499. PubMed ID: 34083781
[TBL] [Abstract][Full Text] [Related]
2. Interleukins and cancer immunotherapy.
Yoshimoto T; Morishima N; Okumura M; Chiba Y; Xu M; Mizuguchi J
Immunotherapy; 2009 Sep; 1(5):825-44. PubMed ID: 20636026
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms and applications of interleukins in cancer immunotherapy.
Anestakis D; Petanidis S; Kalyvas S; Nday CM; Tsave O; Kioseoglou E; Salifoglou A
Int J Mol Sci; 2015 Jan; 16(1):1691-710. PubMed ID: 25590298
[TBL] [Abstract][Full Text] [Related]
4. Interleukins in the treatment of melanoma.
Xu X; Dai W; Li C
Chin Med J (Engl); 2022 Jan; 135(4):393-399. PubMed ID: 34985017
[TBL] [Abstract][Full Text] [Related]
5. Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12.
Floros T; Tarhini AA
Semin Oncol; 2015 Aug; 42(4):539-48. PubMed ID: 26320059
[TBL] [Abstract][Full Text] [Related]
6. Targeting immunometabolism of neoplasms by interleukins: A promising immunotherapeutic strategy for cancer treatment.
Zhu Z; Parikh P; Zhao H; Givens NT; Beck DB; Willson CM; Bai Q; Wakefield MR; Fang Y
Cancer Lett; 2021 Oct; 518():94-101. PubMed ID: 34153401
[TBL] [Abstract][Full Text] [Related]
7. Engineering interferons and interleukins for cancer immunotherapy.
Holder PG; Lim SA; Huang CS; Sharma P; Dagdas YS; Bulutoglu B; Sockolosky JT
Adv Drug Deliv Rev; 2022 Mar; 182():114112. PubMed ID: 35085624
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-armed chimeric antigen receptor-modified T cells for cancer immunotherapy.
Huang Y; Li D; Qin DY; Gou HF; Wei W; Wang YS; Wei YQ; Wang W
Gene Ther; 2018 Jun; 25(3):192-197. PubMed ID: 28820501
[TBL] [Abstract][Full Text] [Related]
9. Role of common-gamma chain cytokines in NK cell development and function: perspectives for immunotherapy.
Meazza R; Azzarone B; Orengo AM; Ferrini S
J Biomed Biotechnol; 2011; 2011():861920. PubMed ID: 21716670
[TBL] [Abstract][Full Text] [Related]
10. IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation.
Ouyang W; O'Garra A
Immunity; 2019 Apr; 50(4):871-891. PubMed ID: 30995504
[TBL] [Abstract][Full Text] [Related]
11. Cancer immunotherapy focusing on the role of interleukins: A comprehensive and updated study.
Samadi M; Kamrani A; Nasiri H; Shomali N; Heris JA; Shahabi P; Ghahremanzadeh K; Mohammadinasab R; Sadeghi M; Sadeghvand S; Shotorbani SS; Akbari M
Pathol Res Pract; 2023 Sep; 249():154732. PubMed ID: 37567033
[TBL] [Abstract][Full Text] [Related]
12. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
[TBL] [Abstract][Full Text] [Related]
13. Cytokine gene-modified vaccines in the therapy of cancer.
Bubenik J
Pharmacol Ther; 1996; 69(1):1-14. PubMed ID: 8857300
[TBL] [Abstract][Full Text] [Related]
14. [Molecular bases of cancer immunology].
Barrera-Rodríguez R; Peralta-Zaragoza O; Madrid-Marina V
Salud Publica Mex; 1995; 37(4):344-53. PubMed ID: 7502157
[TBL] [Abstract][Full Text] [Related]
15. IL-21: roles in immunopathology and cancer therapy.
Søndergaard H; Skak K
Tissue Antigens; 2009 Dec; 74(6):467-79. PubMed ID: 19845910
[TBL] [Abstract][Full Text] [Related]
16. [Prostaglandins, histamine and cancer immunotherapy].
Uotila P
Duodecim; 1993; 109(2):108-18. PubMed ID: 8013314
[No Abstract] [Full Text] [Related]
17. The Role of Sphingolipids in Cancer Immunotherapy.
Giussani P; Prinetti A; Tringali C
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204326
[TBL] [Abstract][Full Text] [Related]
18. Tuning cancer fate: the unremitting role of host immunity.
Calì B; Molon B; Viola A
Open Biol; 2017 Apr; 7(4):. PubMed ID: 28404796
[TBL] [Abstract][Full Text] [Related]
19. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer.
Monjazeb AM; Hsiao HH; Sckisel GD; Murphy WJ
J Immunotoxicol; 2012; 9(3):248-58. PubMed ID: 22734880
[TBL] [Abstract][Full Text] [Related]
20. Interleukins 18 and 21: biology, mechanisms of action, toxicity, and clinical activity.
Logan TF; Robertson MJ
Curr Oncol Rep; 2006 Mar; 8(2):114-9. PubMed ID: 16507221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
